Efficacy and Safety of Dalbavancin As Suppressive Therapy

Clinical trial NCT06899906 · RECRUITING

Trial details

NCT number: NCT06899906
Sponsor: Hospices Civils de Lyon
Status: RECRUITING
Study type: OBSERVATIONAL

Efficacy and Safety of Dalbavancin In Subjects Who Received SAT with DAL For Acute or Chronic Infections Between July 2019 and December 2024

Start date: 2024-10-01
Primary completion: 2025-03-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.